Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)

NCT00845000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

12

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: SCH 420814 10 mg
DRUG: SCH 420814 100 mg
DRUG: Placebo
DRUG: Levodopa
DRUG: Carbidopa

Sponsor

Merck Sharp & Dohme LLC

Collaborators

[object Object]